{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-012404","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.851374+00:00","generated_at":"2026-05-17T09:49:01.463527+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Curanex Pharmaceuticals closes IPO of 3.75M shares at $4.00, raising $15M gross","bullets":["Gross proceeds of $15M from IPO of 3,750,000 shares at $4.00 per share on firm commitment basis.","Net proceeds approximately $12.1M after underwriting discounts and estimated offering expenses.","Common stock began trading on Nasdaq Capital Market on Aug 26, 2025 under ticker CURX.","Underwriters granted 45-day option to purchase up to 562,500 additional shares at $4.00 per share.","Lead underwriter Dominari Securities LLC; co-underwriters Pacific Century Securities LLC and Revere Securities LLC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-012404","json":"https://secwatch.observer/filing/0001493152-25-012404.json","markdown":"https://secwatch.observer/filing/0001493152-25-012404.md","text":"https://secwatch.observer/filing/0001493152-25-012404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/0001493152-25-012404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:49:01.463527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}